The Federal Trade Commission’s (FTCs) Bureau of Consumer Protection today announced the issuance of Health Products Compliance Guidance, the agency’s first revision of its business guidance in this area in nearly 25 years. One major revision is to extend the guidance covering dietary supplements to all health-related products.
The revised guide also reflects updates to other FTC guidance documents, including the guidance on endorsements and testimonials. Among other things, the new guide includes a much more detailed discussion of the amount and type of evidence needed to substantiate health-related claims, with more emphasis on the fact that the FTC, as a general rule, expects high quality randomized, controlled human clinical trials.
Recent Posts
Appropriations Update
As Congress returns from the August recess, its primary goal is to pass the appropriations bills that fund the federal government by September 30, 2025….
Clinical Decision Support for Vestibular Diagnosis: Large-Scale Machine Learning with Lived Experience Coaching
Pastor et al. (2025) developed a machine learning system (MLS) to help make a vestibular diagnosis based on patient symptoms. They utilized diagnostic data from…
Academy Submits Comments on Proposed Revisions to MPFS CY 2026
In response to the Centers for Medicare and Medicaid Services (CMS) Notice of Proposed Rulemaking (NPRM) regarding revisions to Medicare payment policies under the Medicare…